I have pretty much given up following ELN after it was forced to sell on the very cheap half of its alzheimer program. Has there been any development in identifying markers to identify those patients at risk for PML?
My wife is going into a study on this. As I understand it, they will do blood draws and run assays to identify and track JCV titers as a means of assessing the risk of PML.
It is a 3 year study so no near term relief for those concerned about the risk of PML on T.
ij
There are times when rules and precedents cannot be broken; others when they cannot be adhered to with safety. (Thomas Joplin)